ProfileGDS4459 / ENSG00000182000
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 2% 3% 5% 1% 9% 1% 6% 6% 5% 4% 11% 2% 5% 32% 1% 1% 5% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 12.152
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.393
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 31.95
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.131
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.379
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 61.71
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.026
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 81.976
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 91.825
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 101.934
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.7111
GSM623475group B, liver allograft wedge biopsie placebo treatment 21.482
GSM623476group B, liver allograft wedge biopsie placebo treatment 31.855
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.8532
GSM623478group B, liver allograft wedge biopsie placebo treatment 51.391
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.11
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.545